Jacobs Levy Equity Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9M Buy
+582,660
New +$11.2M 0.05% 269
2024
Q2
Sell
-185,076
Closed -$918K 951
2024
Q1
$918K Buy
+185,076
New +$1.18M ﹤0.01% 730
2023
Q4
Sell
-292,593
Closed -$2.03M 968
2023
Q3
$2.03M Buy
292,593
+112,572
+63% +$679K 0.01% 554
2023
Q2
$1.04M Sell
180,021
-951,008
-84% -$6.15M 0.01% 694
2023
Q1
$7.19M Buy
1,131,029
+32,541
+3% +$310K 0.04% 334
2022
Q4
$12.9M Buy
1,098,488
+472,507
+75% +$5.75M 0.09% 248
2022
Q3
$7.41M Buy
+625,981
New +$9.14M 0.06% 314

Other funds holding ALHC

Jacobs Levy Equity Management's ALHC Position: Q2 2026 in Review

Jacobs Levy Equity Management opened a new position in Alignment Healthcare (ALHC) in Q2 2026: 582,660 shares worth $13.9M. The stake represents 0.05% of the portfolio and ranks #269 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in ALHC as recently as Q1 2024.

Jacobs Levy Equity Management first reported a position in ALHC in Q3 2022 and has held it in 7 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Jacobs Levy Equity Management held 582,660 shares of Alignment Healthcare worth $13.9M as of Q2 2026.
  • Alignment Healthcare was a new Jacobs Levy Equity Management position in Q2 2026.
  • Alignment Healthcare made up 0.05% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #269 holding.
  • Jacobs Levy Equity Management first reported a position in Alignment Healthcare in Q3 2022 and has held it in 7 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.